ClinicalTrials.Veeva

Menu

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

A

Alberta Health services

Status

Unknown

Conditions

Hematologic Malignancy

Treatments

Drug: intravenous busulfan

Study type

Interventional

Funder types

Other

Identifiers

NCT00156858
717905172
10156

Details and patient eligibility

About

A study of pharmacokinetics of daily intravenous busulfan

Full description

A study of pharmacokinetics of daily intravenous busulfan

Enrollment

200 estimated patients

Sex

All

Ages

Under 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing transplantation

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems